Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06329401 ×

NCT06329401

This funder is selected. Its supporting articles are shown below.

NCT063294011

Articles mentioning NCT06329401

1 articles · page 1 of 1

Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis

bmjresp · abstract · 2025-12-25 · 1 matching annotations

75.7%

NCT06329401 pulmonary fibrosis pirfenidone PARI Pharma GmbH AP01 interstitial lung diseases (ILDs)PPF

…solution CT from baseline to 52 weeks.Trial registration number NCT06329401.…